Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/2008
10/23/2008US20080260644 Adjust concentration of chloride channel moderators within brain
10/23/2008DE102007019162A1 Verwendung von EGFL7 zur Modulation von Zellen Use of EGFL7 to modulate cell
10/23/2008CA2684534A1 Constructs for enhancement of gene expression in muscle
10/23/2008CA2683562A1 Sirtuin based methods and compositions for treating .beta.-catenin-related conditions
10/23/2008CA2683469A1 Genetic suppression and replacement
10/23/2008CA2683314A1 Isolated nucleic acid molecules corresponding to micro rna 145 (mirna-145) and their use in treating colon cancer
10/23/2008CA2671961A1 Enhanced retinal delivery of a nucleic acid through iontophoresis
10/22/2008EP1983057A2 Improved AAV vectors for gene therapy
10/22/2008EP1983055A1 Albumin fusion proteins
10/22/2008EP1983053A2 Cell distribution control for cells within bioartifical organs
10/22/2008EP1982990A1 Cytokine receptor common gamma chain like
10/22/2008EP1982704A2 New molecular target of neurotoxicity
10/22/2008EP1981902A2 Nogo receptor antagonists
10/22/2008EP1981838A2 Process for synthesis of glycomimicking cationic amphiphiles
10/22/2008EP1981548A2 Enhanced production of infectious parvovirus vectors in insect cells
10/22/2008EP1981482A1 Process for preparing a particle comprising a biological molecule and a carrier polymer
10/22/2008EP1368371B1 Transfection complexes
10/22/2008EP1266022B1 Cell-specific adenovirus vectors comprising an internal ribosome entry site
10/22/2008EP0828519B1 Recombinant viral vector system
10/22/2008CN101291949A Aptamers comprising arabinose modified nucleotides
10/22/2008CN101291678A Carrier composition for nucleic acid transport
10/22/2008CN101291653A Lipid encapsulated interfering rna
10/22/2008CN101288773A Complex type transgene lung cancer general tumor vaccine
10/22/2008CN101288671A Use of Triperugium wilfordii monomeric compound for increasing gene expression efficiency mediated by adeno-associated virus vector and subsidiarily treating neurodegenerative disease
10/22/2008CN100427599C ALBSIN/IL-18MAT hybridization cytokine
10/21/2008US7439335 Synthetic antigen presenting matrix/biological scaffold comprising immobilized major histocompatibility complex for use in identifying modulator for treatment and prevention of autoimmune, allergy and cancer disorders
10/21/2008US7439333 Vascular endothelial growth factor 2
10/21/2008US7439329 Isolated nucleic acid encoding GEF-H1b polypeptide (Guanine nucleotide exchange factors); diagnosing abnormal cell proliferation and drug screening; measuring phosphorylation by p-21 activated kinase
10/21/2008US7439320 Cripto tumour polypeptide
10/21/2008US7439233 Vaccine for house dust mite allergen using naked DNA
10/21/2008US7439066 Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (LCMV)
10/21/2008US7439065 Helper virus-free AAV production
10/21/2008US7439060 Independent helper virus packaging cell line for propagating viral vectors
10/21/2008US7439059 Compositions and methods for activating genes of interest
10/21/2008US7438918 Lipid A deficient mutants of Neisseria meningitidis
10/21/2008US7438902 treating diabetes mellitus; isolating a nestin-positive pancreatic stem cell from a pancreatic islet of a donor; transferring the stem cell into the patient, wherein it differentiates into an insulin-producing cell; across allogeneic or xenogeneic barriers and graft rejection does not occur
10/21/2008CA2387383C Use of anti-ferritin monoclonal antibodies in the treatment of some cancers
10/21/2008CA2301401C Determining the transforming capability of agents
10/21/2008CA2230452C Novel 3' terminal sequence of hepatitis c virus genome and diagnostic and therapeutic uses thereof
10/21/2008CA2220226C Improved methods for transfecting t cells
10/21/2008CA2162361C Antisense oligonucleotides which combat aberrant splicing and methods of using the same
10/16/2008WO2008124724A1 Raav vector compositions having tyrosine-modified capsid proteins and methods for use
10/16/2008WO2008124660A2 Methods and compositions for the treatment of cancer
10/16/2008WO2008124494A1 Enrichment of tissue-derived adult stem cells based on retained extracellular matrix material
10/16/2008WO2008124331A1 Novel sequences and dna vaccines against avian flu
10/16/2008WO2008124166A2 Fusion proteins of collagen-binding domain and parathyroid hormone
10/16/2008WO2008123308A1 Therapeutic agent comprising vasohibin
10/16/2008WO2008123202A1 METHOD FOR INHIBITION OF SIGNALING THROUGH ErbB2, SIGNALING INHIBITOR FOR USE IN THE METHOD, AND USE OF THE SIGNALING INHIBITOR
10/16/2008WO2008103993A3 Compositions and methods for treating glycogen storage diseases
10/16/2008WO2008100922A3 Methods and compositions related to prefoldin and its regulation
10/16/2008WO2008088882A3 Methods of generating cardiomyocytes
10/16/2008WO2008076857A3 Method and compositions for inhibiting mage protein interaction with kap-1
10/16/2008WO2008054770A3 Use of tumor necrosis factor-alpha p75 receptor for the reduction of inflammation
10/16/2008WO2007012944A9 Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus
10/16/2008WO2006086746A3 Homogeneous neural precursor cells
10/16/2008WO2006069329A3 Therapy inhalation involving antisense oligonucleotides for treating idiopathic pulmonary fibrosis
10/16/2008US20080255643 Compositions and methods relating to prevention of chemotherapy-induced alopecia
10/16/2008US20080254527 VON WILLEBRAND FACTOR (vWF) - CLEAVING PROTEASE
10/16/2008US20080254109 Delivering therapeutic nucleic acid into adjacent normal heart tissue; inducing angiogenesis and collateral blood vessel formation
10/16/2008US20080254061 Recombinant mycobacterium segmentis elicits HIV-1 envelope-specific CD8+ T cell responses; combination vaccines
10/16/2008US20080254050 Immunotherapeutic comprising very small particles from neisserial outer memebrane protein and/or vascular endothelial growth factor for use in targeting a nd treating cell proliferative, inflammatory autoimmune and vision defects
10/16/2008US20080254034 Microbial membrane protein for use in diagnosis, prevention and treatment of gramnegative bacterial infection
10/16/2008US20080254028 Caspase-8 interacting polypeptide (Cari) for use in identifying modulators for prevention and treatment of autoimmune, inflammatory, connective tissue and liver disorders
10/16/2008US20080254006 Treatment of alopecia by micropore delivery of stem cells
10/16/2008US20080254004 Homogeneous Neural Precursor Cells
10/16/2008DE102007017290A1 Use of viologen dendrimer having 4, 4'-bipyridinium structure for e.g. transporting oligonucleotides, ribonucleic acid, and single and double stranded DNA in eukaryotic cells; and therapeutic methods in humans and animals
10/16/2008CA2720097A1 Raav vector compositions having tyrosine-modified capsid proteins and methods for use
10/16/2008CA2686933A1 Methods and compositions for the treatment of cancer
10/16/2008CA2683862A1 Fusion protein of collagen-binding domain and parathyroid hormone
10/16/2008CA2682317A1 Enrichment of tissue-derived adult stem cells based on retained extracellular matrix material
10/15/2008EP1980617A1 Improved expression of HIV polypeptides and production of virus-like particles
10/15/2008EP1979364A2 Rna containing modified nucleosides and methods of use thereof
10/15/2008EP1978999A2 Isolated mcpip and methods of use
10/15/2008EP1740699A4 Connexin 40 tissue specific gene mutations
10/15/2008EP1446162B1 Combination motif immune stimulatory oligonucleotides with improved activity
10/15/2008EP1372704B1 Monocyte-specific particulate delivery vehicle
10/15/2008EP1303600B1 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
10/15/2008EP1242456B1 Scfv antibodies against disease associated molecules
10/15/2008EP1233980B1 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence
10/15/2008EP1107785B1 Method of dna vaccination
10/15/2008EP1083882B1 Poly-l-lysine grafted with lactose or galactose-polyethylene glycol as polymeric gene carrier
10/15/2008EP0870036B1 Synthetic mammalian alpha-n-acetylglucosaminidase and genetic sequences encoding same
10/15/2008CN101287831A T-cell receptor and nucleic acid encoding the receptor
10/15/2008CN101287501A Nod1 as an anti-tumor agent
10/15/2008CN101284137A Nm gene formulations for promoting mink growing
10/15/2008CN101284134A Carrier for gene transmission and preparation method thereof and application
10/15/2008CN100425702C Lentiviral triplex DNA, and vectors and recombinant cells contg. same
10/15/2008CN100425697C Nucleotid sequence of human interleukin 21 and method and application of producing matured human interleukin 21
10/15/2008CN100425694C Method of inducing embryo stem cell to differentiate toward pancreatic cell
10/15/2008CN100425291C O-type foot-and-mouth disease virus poly-gene duplication defect type adenovirus active carrier vaccine and process for preparing the same
10/15/2008CN100425290C CCA gene vaccine, and its establishing method and use for preparing vaccine for preventing and treating tumour
10/14/2008US7435806 Detection of preferential transcription factor; obtain library, screen with probe, detect hybridization, recover clone, monitor transcriptional activity of protein codes in cloned nucleotide sequences
10/14/2008US7435723 In situ administering into vascular system by injection; gene therapy; controlling gene expression
10/14/2008US7435719 Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods
10/14/2008US7435718 CXCR4 antagonist treatment of hematopoietic cells
10/14/2008US7435596 Modified cell line and method for expansion of NK cell
10/14/2008US7435595 Using prokaryotic histone protein as tool in transfer of heterologus nucleotide sequences into cells; improving exogenous gene expression
10/14/2008US7435410 Methods of treatment with interferson and albumin fusion protein
10/14/2008CA2339244C Methods of ophthalmic administration
10/14/2008CA2237529C Vaccine compositions for intranasal administration comprising chitosan and use thereof
1 ... 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 ... 870